Psoriasis Drug Market 2018-2024 : Industrial Forecast and Trends
24-May-2018 | Number of pages: 205 | Report Id: BMRC PH 120 | Report Format: | Status: Upcoming

Outlook of Global Psoriasis Drug Market: Research Report during 2018-2024

Brandessence Market Research is working on a new report titleGlobal Psoriasis Drug Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2018-2024″.Increasing healthcare expenditure, improvement in Psoriasis Research and Development expenditure and rising demand for newer Psoriasis medicines are major key factor which drives the Global Psoriasis Drug Market.

Global Psoriasis Drug Market Reports –

Psoriasis is a genetically programmed inflammatory disease caused by an overactive immune system. It causes the rapid buildup of skin cells. This buildup of cells causes scaling on the skin’s surface.It typically affects the outside of the elbows, knees or scalp, though it can appear on any location. The symptoms of Psoriasis are red patches of skin covered with thick, silvery scales, Dry & cracked skin, Thickened or pitted or ridged nails and small scaling spots. There are 7 types of Psoriasis such as Plague Psoriasis, Guttate Psoriasis, Pushtular Psoriasis, Inverse Psoriasis, erythrodermic Psoriasis and Psoriasis in children. Psoriasis is diagnosed by Physical Examination and Medical History; also Skin Biopsy is carried out. Psoriasis treatments decrease inflammation and clear the skin. Treatments are divided into three main types such as topical treatments, light therapy and systemic medications. A combination Therapy is newer treatment that is used is to combine two types of systemic drugs i.e., a traditional drug and a biologic. Biologics usually take a time to work. Combining a biologic with a faster-acting systemic drug, such as cyclosporine, is usually more effective and safe. Many doctors are prescribing combination therapies due to faster, longer-lasting results &fewer side effects, requiring lower doses, which is likely to boost Global Psoriasis Drugs Market.

Global Psoriasis Drug Market is segmented on the basis of Product, Therapy, Distribution Channel and Geography. On the Basis ofProduct, Global Psoriasis Drug Marketis classified as TNF Inhibitors, Interleukin Blockers, Vitamin D Analogues or Combinations and Others. On the basis of TherapyGlobal Psoriasis Drug Marketis classified into Topical Therapeutic Drugs, Systemic Therapeutic Drugs, Combinations Therapy andothers. On the basis of Distribution channel Global Psoriasis Drug Market is classified into Hospital Pharmacy, Drug Stores, Online Pharmacy and Others.

The regions covered in Global Psoriasis Drug Market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, Global Melanoma Drug Market sub divided in to U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.

Key Players for Global Psoriasis Drug Market Reports –

Global Psoriasis Drug Market reports cover prominent players like Eli Lilly, Pfizer Inc., Janssen Biotech Inc., Celgene Corporation, Glenmark Pharmaceuticals Limited, Takeda Pharmaceutical Company Limited, Stiefel Laboratories Inc. (GlaxoSmithKline plc)., Novartis AG, Amgen Inc., Biogen Idec, Johnson & Johnson, AstraZeneca, Boehringer Ingelheim, Sun Pharmaceuticals Industries Ltd., Valeant Pharmaceuticals International, Inc., Biocon Limited, Cipla Ltd., Rowan Bioceuticals Private Limited, LEO Pharma, G & W Laboratories Inc., Win Medicare Pvt. Ltd., Merck and Co. Inc., Abbvie Inc. and others.

Global Psoriasis Drug Market Dynamics –

Growing geriatric population and prevalence of psoriasis is the most importantdriving factor of the Global Psoriasis Drug Market. The other market driving factors for the global psoriasis treatment market is growing awareness, rise in risk factors such as autoimmune diseases, diabetes etc. and greater exposure to environmental factors  such as chemicals, allergens etc. As aging population increases the risk of Psoriasis and demand for Psoriasis pharmacotherapy is increases. The market will introduce the blockbuster drugs such as Vicodin and Simponi, apart from those other medications are also present in the pipeline.

The market’s constraints include lack of effective and permanent treatment and low level of awareness as to the benefits of Psoriatic pharmacotherapy has also been inhibiting growth. There is no cure for Psoriasis and most treatments are either symptomatic or temporary in nature. Other market restraints include high cost of newly launched biologics i.e., Rs 300000- Rs 600000 per annum and patent expiry of a number of blockbuster drugs such as humira, enbrel and remicade etc. Also side effects related with present medications such as hypertension, liver and kidney damage etc.

The recent market trends include vast potential reflected by novel acting biologics such as TNF inhibitors, IL-17 inhibitors etc. Therefore novel drug development especially involving biologics will be the best strategy and will lead to fast growth of the market along with less marketing expenditure. Thus product development is the critical strategy to be a market leader of Global Psoriasis Drug Market.

Global Psoriasis Drug Market Regional Analysis –

North America is having highest market share for Global Psoriasis Drug Market in the near future. The remarkable rise in the patient pool suffering from Psoriasis is likely to increase this regional market over the coming years. The existence of better drug manufacturers is expected to have positive impact on the North America market for Psoriasis treatment in the future.

Also Europe having a high position in the Global Psoriasis Drug market is likely to experience a decline in the demand Psoriasis treatment, following a powerful competition from biosimilars over the next few years. Latin America and Asia Pacific are projected to observe a significant growth in the Global Psoriasis Drug market over the next few years.Asia Pacific is expected to be the fastest-growing region owing to the large population and changing lifestyle habits such as smoking.Furthermore, increase in awareness through various government and NGO campaigns of disease and government initiatives for improving health care facilities are expected to boost the regional market to a certain extent.

Key Benefits for Global Psoriasis Drug Market Reports –

  • Global Psoriasis Drug Market report covers in depth historical and forecast analysis.
  • Global Psoriasis Drug Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Global market sale (K Units), Global market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.
  • Global Psoriasis Drug Market report helps to identify opportunities in market place.
  • Global Psoriasis Drug Market report covers extensive analysis of emerging trends and competitive landscape.

Global Psoriasis Drug Market Segmentation

Global Psoriasis Drug Market: By Product Analysis

  • TNF Inhibitors
  • Interleukin Blockers
  • Vitamin D Analogues or Combinations
  • Others

Global Psoriasis Drug Market: By Therapy Analysis

  • Topical Therapeutic Drugs
  • Systemic Therapeutic Drugs
  • Combinations Therapy
  • Others

Global Psoriasis Drug Market: By Distribution Analysis

  • Hospital Pharmacy
  • Drug Stores
  • Online Pharmacy
  • Others

Global Psoriasis Drug Market: By Regional & Country Analysis

  • North America
    • U.S.
    • Mexico
    • Canada
  • Europe
    • UK
    • France
    • Germany
    • Italy
  • Asia Pacific
    • China
    • Japan
    • India
    • Southeast Asia
  • Latin America
    • Brazil
  • The Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Global Psoriasis Drug Market 2018-2024

Our 205 pages report provides 72 tables, 65 charts and graphs. The report covers historical and forecast data of North America, Europe, Asia Pacific, Latin America and Middle East & Africa. Our study focuses on the most lucrative areas in the industry and the future market prospects. Market covers financial results, trends, opportunities and revenue predictions from 2018 to 2024. Significant rise in research and development activities by leading vendors.

Why you should buy this report:

  • To receive a comprehensive analysis of the prospects for Global Psoriasis Drug Market
  • To receive forecasts of Global Psoriasis Drug Market Sales in leading country markets from 2018-2024, including leading and emerging country from developed and developing regions
  • To discover the views of experts in the Global Psoriasis Drug Market sector
  • To determine the forces and factor that influences the market for Global Psoriasis Drug Market: drivers, restraints, opportunities and threats
  • To find out where the Global Psoriasis Drug Market is heading – both technologically and commercially from 2018-2024
  • Report Include tables of contract/projects and its value and description by  region and Country

Global Psoriasis Drug Market: By Region Analysis

 

  2017

(USD Million)

2024

(USD Million)

2017 Market Share (%) CAGR (%)

2018-2024

Consumption

(K Unit)

Global XX XX XX XX XX
North America XX XX XX XX XX
Europe XX XX XX XX XX
Asia Pacific XX XX XX XX XX
Latin America XX XX XX XX XX
Middle East & Africa XX XX XX XX XX
Global XX XX XX XX XX

Source: Brandessence Market Research, 2018

Global Psoriasis Drug Market: ByProduct Analysis

 

  2017

(USD Million)

2024

(USD Million)

2017 Market Share (%) CAGR (%)

2018-2024

Consumption

(K Unit)

TNF Inhibitors XX XX XX XX XX
Interleukins Blockers  XX XX XX XX XX
Vitamin D Analogues or Combinations XX XX XX XX XX
Others XX XX XX XX XX

Source: Brandessence Market Research, 2018

Global Psoriasis Drug Market: By Therapy Analysis

  2017

(USD Million)

2024

(USD Million)

2017 Market Share (%) CAGR (%)

2018-2024

Consumption

(K Unit)

Topical Therapeutics Drugs XX XX XX XX XX
Systemic Therapeutic Drugs XX XX XX XX XX
Combination Therapy XX XX XX XX XX
Others XX XX XX XX XX

Source: Brandessence Market Research, 2018

Global Psoriasis Drug Market: By Distribution Channel Analysis

 

  2017

(USD Million)

2024

(USD Million)

2017 Market Share (%) CAGR (%)

2018-2024

Consumption

(K Unit)

Hospital Pharmacy XX XX XX XX XX
Drug Stores XX XX XX XX XX
Online Pharmacy XX XX XX XX XX
Others XX XX XX XX XX

Source: Brandessence Market Research, 2018

Why You Must Buy This Report:

  • This report features news, insights, the latest developments and an in depth survey ofGlobal Psoriasis Drug Market with up-to-date analysis as well as tables, graphs and charts. This report is a vital addition to gaining an understanding of this market sector and will give your company ‘the edge’ on your competitors.

Email me today to order this report or to ask for assistance. I look forward to receiving your email on sales@brandessenceresearch.com

Companies Mentioned in This Report,

  • Eli Lilly
  • Pfizer Inc.
  • Janssen Biotech Inc.
  • Celgene Corporation
  • Glenmark Pharmaceuticals Limited
  • Takeda Pharmaceutical Company Limited
  • Stiefel Laboratories Inc. (GlaxoSmithKline plc)
  • Novartis AG
  • Amgen Inc.
  • Biogen Idec
  • Johnson & Johnson
  • AstraZeneca
  • Boehringer Ingelheim
  • Sun Pharmaceuticals Industries Ltd
  • Valeant Pharmaceuticals International, Inc.
  • Biocon Limited
  • Cipla Ltd
  • Rowan Bioceuticals Private Limited
  • LEO Pharma
  • G & W Laboratories Inc.
  • Win Medicare Pvt. Ltd
  • Merck and Co. Inc.
  • Abbvie Inc.
  • Others

 

Table of Content

  1. Chapter – Report Methodology
    • Research Process
    • Primary Research
    • Secondary Research
    • Market Size Estimates
    • Data Triangulation
    • Forecast Model
    • USP’s of Report
    • Report Description
  2. Chapter – Global Psoriasis Drug Market Overview: Qualitative Analysis
    • Market Introduction
    • Executive Summary
    • Global Psoriasis Drug Market Classification
    • Market Drivers
    • Market Restraints
    • Market Opportunity
    • Global Psoriasis Drug Market: Trends
    • Porter’s Five Forces Analysis
      • Bargaining Power of Suppliers
      • Bargaining Power of Consumers
      • Threat of New Entrants
      • Threat of Substitute Product and Services
      • Competitive Rivalry within the Industry
    • Market Attractiveness Analysis
      • Market Attractiveness Analysis by Segmentation
      • Market Attractiveness Analysis by Region
  1. Chapter – Global Psoriasis Drug Market Overview: Quantitative Analysis
    • Global Psoriasis Drug Market Production (K Unit), Market Share (%) and Growth Rate (%), 2014- 2024
    • Global Psoriasis Drug Market Consumption (K Unit), Market Share ( %) and Growth Rate, 2014- 2024
    • Global Psoriasis Drug Market Revenue (USD Million), Market Share (%) and Growth Rate (%), 2014- 2024
  2. Chapter – Global Psoriasis Drug Market: by Product
  3. Chapter – Global Psoriasis Drug Market: by Therapy
  4. Chapter – Global Psoriasis Drug Market: by Distribution Channel
    • Global Psoriasis Drug Market (USD Million), by Manufacturer, 2014 – 2024
    • Global Psoriasis Drug Market Production (K Unit), by Manufacturer, 2014 – 2024
    • Global Psoriasis Drug Market Consumption (K Unit), Manufacturer, 2014 – 2024
    • Global Psoriasis Drug Market Share (%), by Manufacturer, 2017
    • Global Psoriasis Drug Market Price (USD/Unit), by Manufacturer, 2014 – 2024
    • Global Psoriasis Drug Market Revenue Growth Rate (%), by Manufacturer, 2014 – 2024
    • Merger & Acquisition
    • Collaborations and Partnership
    • New Product Launch
  5. Chapter – Global Psoriasis Drug Market: Regional Analysis
    • North America
    • North America Global Psoriasis Drug Market Revenue (USD Million) and Growth Rate (%), 2014 – 2024.
    • North America Global Psoriasis Drug Market Revenue (USD Million) By Country, 2014 – 2024.
    • North America Global Psoriasis Drug Market Revenue Market Share (%) By Country, 2014 – 2024.
    • North America Global Psoriasis Drug Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2014 – 2024.
    • North America Global Psoriasis Drug Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2014 – 2024.
    • North America Global Psoriasis Drug Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2014 – 2024.
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa
  6. Chapter – Company Profiles
    • Eli Lilly
    • Overview
    • Financials
    • Product portfolio
  • Global Psoriasis Drug Market Revenue (USD Million), Production (K Unit), Consumption (K Unit) and Market Share (%), 2014 – 2017
    • Global Psoriasis Drug Market Share (%), 2014 – 2017
    • Business strategy
    • Recent developments
  • Pfizer Inc.
  • Janssen Biotech Inc.
  • Celgene Corporation
  • Glenmark Pharmaceuticals Limited
  • Takeda Pharmaceutical Company Limited
  • Stiefel Laboratories Inc. (GlaxoSmithKline plc)
  • Novartis AG
  • Amgen Inc.
  • Biogen Idec
  • Johnson & Johnson
  • AstraZeneca
  • Boehringer Ingelheim
  • Sun Pharmaceuticals Industries Ltd
  • Valeant Pharmaceuticals International, Inc.
  • Biocon Limited
  • Cipla Ltd
  • Rowan Bioceuticals Private Limited
  • LEO Pharma
  • G & W Laboratories Inc.
  • Win Medicare Pvt. Ltd
  • Merck and Co. Inc.
  • Abbvie Inc.
  • Others
  1. Chapter – Market Research and Findings

 

Eli Lilly

Pfizer Inc.

Janssen Biotech Inc.

Celgene Corporation

Glenmark Pharmaceuticals Limited

Takeda Pharmaceutical Company Limited

Stiefel Laboratories Inc. (GlaxoSmithKline plc).

Novartis AG

Amgen Inc.

Biogen Idec

Johnson & Johnson

AstraZeneca

Boehringer Ingelheim

Sun Pharmaceuticals Industries Ltd.

Valeant Pharmaceuticals International, Inc.

Biocon Limited, Cipla Ltd.

Rowan Bioceuticals Private Limited

LEO Pharma

G & W Laboratories Inc.

Win Medicare Pvt. Ltd.

Merck and Co. Inc.

Abbvie Inc.

Others.